Feedback / Questions
bryostatin 1 (NSC 339555) - Synaptogenix
https://www.prnewswire.com/news-releases/synaptogenix-completes-patient-enrollment-in-nih-sponsored-phase-2b-alzheimers-disease-trial-301528016.html
Apr 19, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next